Recent research published in Nature Microbiology investigates the biological mechanisms that differentiate sepsis survivors from non-survivors, moving beyond traditional immunology to include microbiome-driven factors. By studying mouse models and human clinical samples, the authors discovered that peritoneal macrophages in survivors exhibit a specific genetic signature that suppresses harmful inflammation. This protective state is heavily influenced by tryptophan metabolites and indoles, which activate the aryl hydrocarbon receptor (AhR) to regulate the host's immune response. The study demonstrates that treatments like fecal microbiota transplantation (FMT) can improve survival by restoring these beneficial microbial products.  ...